Reinício das Válvulas Pulmonares Review and Ads Breakdown

What Is Reinício das Válvulas Pulmonares

Reinício das Válvulas Pulmonares is presented as a respiratory support supplement for people with breathing problems associated in the VSL with COPD, chronic bronchitis, coughing, wheezing, and shortness of breath. The presentation says it is a natural formula designed to reopen or restore what it calls jammed lung valves.

The product is not introduced as a general wellness capsule. It is positioned as a direct alternative to the mainstream respiratory-care path. The VSL repeatedly contrasts the formula with inhalers, oxygen therapy, and prescription medications. According to the presentation, inhalers may open airways temporarily, but they do not address the alleged root cause.

The speaker identified as Dr. Barbara O'Neill claims the formula contains mullein leaf extract, organic thyme extract, ginger root complex, licorice root, and vitamin D3. She also claims the formula depends on precise ratios and extraction methods. However, the transcript does not provide a full Supplement Facts label, exact dosages, serving size, manufacturing details, third-party testing, contraindications, or safety disclosures.

The product is bundled with a broader system. The VSL says buyers receive the Complete Lung Freedom System, a Complete Lung Recovery Toolkit, an Emergency Valve Reset Protocol, a Lung Renewal Food Plan, email access to a clinical team, and a chance for 100 people to visit a retreat for seven days at no cost.

The offer price in the transcript is $39 per bottle. The VSL claims that this is manufacturing cost and warns that pharmacy distribution could raise the price above $200 per bottle. It also says the private-patient version of the materials would normally cost more than $2,000.

The central promise is not subtle. According to the presentation, users may be able to wake up without coughing, walk farther without stopping, reduce inhaler use, climb stairs, and breathe deeply again. The VSL even uses language about reversing COPD and other respiratory conditions. From an editorial perspective, that language is a major point to scrutinize. COPD is serious, and a supplement should not be treated as a cure or replacement for medical care.

The Problem It Targets

The VSL targets one of the most frightening physical experiences: not being able to breathe. The opening story, voiced through a Snoop Dogg persona, begins in a home studio. The narrator says he cannot do the one thing a newborn baby does automatically: breathe. That opening is designed to make breathlessness feel immediate, personal, and humiliating.

The pain points are repeated through several characters. The Snoop-style narrator describes chest tightness, cutting a studio session short, leaning over after walking from a car to a door, and nights where the walls feel like they are closing in. Sam Elliott's testimonial intensifies the same pattern. He says he could not make it from his truck to the grocery store without stopping three times. He describes waking up gasping, sitting at the kitchen table at 4 a.m., and coughing during Christmas dinner while his grandkids watched.

The emotional target is not only physical discomfort. It is loss of identity. The VSL chooses people known for voice, strength, performance, masculinity, endurance, and public presence. Snoop Dogg is framed as a voice of a generation who could be silenced. Sam Elliott is framed as a stuntman who survived explosions and horseback work but could not fight COPD. Later celebrity-style testimonials mention a 94-year-old director, a 91-year-old singer, and a rock performer who says he can do a three-hour set again.

This is a deliberate angle. The problem is not described as a minor health inconvenience. It is portrayed as dignity being stolen. The VSL says the target viewer may be planning life around oxygen tanks, missing family moments, feeling ashamed in public, spending hundreds of dollars on medications, and fearing the day they can no longer speak.

The presentation also targets frustration with conventional care. Doctors are shown as offering inhalers for life, oxygen therapy, and end-of-life planning. The VSL claims those approaches treat symptoms rather than root cause. That framing is important: the offer is not merely selling a supplement; it is selling a way to reject a frightening medical identity.

The stated enemy is the belief that COPD is a life sentence. The presentation says viewers have been sold a bad beat and claims, in the narrator's words, that people are not broken but being kept sick. This is emotionally powerful, but it also raises risk. When a VSL suggests that prescribed therapies are part of a profit-driven trap, vulnerable viewers may be tempted to distrust legitimate care. That is why the claims need careful separation from medical fact.

How Reinício das Válvulas Pulmonares Works

According to the VSL, Reinício das Válvulas Pulmonares works by targeting tiny structures the speaker calls alveolar capillary junctions. The presentation describes them as microscopic valves between the air sacs and bloodstream. In the VSL's analogy, these valves are like tiny doors that allow oxygen in and toxins out.

The claimed problem is that years of exposure to dust, smoke, pollution, cleaning chemicals, and other microscopic particles cause these valves to seize shut. Once jammed, the VSL says toxins cannot escape the bloodstream and instead circulate back into the lungs. The presentation names this loop the outlaw mechanism, because the blood supposedly turns against the lungs instead of helping them heal.

The analogy used in the VSL is a house with painted-shut windows. Fresh air may be pumped in, but stale toxic air remains trapped. This is how the presentation explains why inhalers may only provide temporary relief. It says products like Symbicort, Advair, and Albuterol may open airways or push air into inflamed passages, but do not reopen the jammed valves.

The proposed solution is the formula's five-compound blend. The speaker claims mullein dissolves microscopic gunk jamming the valve mechanisms. She says thyme extract relaxes muscles around the bronchial tubes and clears inflammatory debris. Ginger root complex is described as reducing swelling and boosting blood flow. Licorice root is described as repairing damaged valve tissue and preventing scarring. Vitamin D3 is described as critical for lung repair, with the VSL claiming that 87% of COPD patients are severely deficient.

These are the claims made by the presentation. The transcript does not provide independent verification, peer-reviewed citations, dosage data, safety data, or diagnostic criteria. It also uses very strong language about reversing COPD and other respiratory conditions. A careful reader should treat the mechanism as the product's marketing hypothesis, not as a confirmed medical explanation.

One notable inconsistency appears between the main VSL and the ad transcript. The main VSL sells a bottle-based supplement formula. The ad says a glass of salt water can reverse lung disease in a few days and calls it a fridge trick originally used by astronauts. It later shifts to a 100% natural solution and three simple steps. That may be a traffic hook rather than the final product mechanism, but it is still worth noting because it creates a gap between ad promise and VSL offer.

Key Ingredients and Components

The transcript does disclose a specific ingredient list, though not a full label. The named ingredients are mullein leaf extract, organic thyme extract, ginger root complex, licorice root, and vitamin D3.

Mullein leaf extract is presented as the first compound. The VSL says European farmers used it for centuries when animals had breathing problems. The claimed role in this formula is to dissolve microscopic gunk jamming the valve mechanisms. The speaker compares it to WD40 for your lung valves. That is vivid marketing language, not a clinical measurement.

Organic thyme extract is the second ingredient. The presentation emphasizes that this is not ordinary kitchen thyme, but a concentrated extract containing compounds called thymols. According to the VSL, these compounds relax tiny muscles around the bronchial tubes while clearing inflammatory debris that blocks valve pathways.

Ginger root complex is described as more than a nausea remedy. The presentation calls ginger one of nature's most powerful anti-inflammatories. It claims the ingredient reduces swelling that is choking valves shut and boosts blood flow to repair damaged lung tissue.

Licorice root is included next. The VSL says it contains glycyrrhizin, which allegedly repairs damaged valve tissue and prevents scarring that keeps valves stuck. The speaker clarifies that the formula will not taste like candy. The transcript does not discuss safety considerations around licorice or glycyrrhizin, which is a gap a cautious buyer should notice.

Vitamin D3 is the final named component. The VSL says 87% of COPD patients are severely deficient in vitamin D and claims vitamin D is critical for lung repair. It frames D3 as a necessary cofactor without which the body cannot heal properly.

The product's technical differentiator is not simply the ingredients. The speaker says the key is the precise ratios and extraction methods. Too little, according to the presentation, and the valves stay jammed. Too much, and the system is overwhelmed. That claim helps justify why viewers should buy this formula rather than assemble common ingredients themselves.

The VSL also sells components beyond the bottle. The Emergency Valve Reset Protocol is positioned as a 60-second technique for episodes when the user cannot catch their breath. The Lung Renewal Food Plan claims to reveal 17 foods that support valve function and eight foods that secretly jam valves shut. The clinical team email access is positioned as high-touch support for the first 60 days. None of these materials are shown in detail in the transcript.

The VSL Hook and Story

The core VSL hook is a suppressed respiratory breakthrough: a natural formula that allegedly reopens jammed lung valves and could make inhalers and oxygen therapy unnecessary. That is the big promise. Everything else in the script supports it.

The first voice is the Snoop Dogg-style opener. It begins in a personal, cinematic way: home studio, sacred space, voice of a generation, unable to breathe. The hook is not clinical at first. It is identity-based. The narrator says he could be shut down forever, not by government or haters, but by a tiny invisible glitch experts did not warn him about.

Then the VSL introduces the villain. The narrator says people have been played, that the system is a lie, and that a multibillion-dollar hustle depends on people not discovering they can flip the script on their lungs in 17 days. This creates the classic direct-response tension: hidden truth versus corrupt establishment.

The story then shifts to conventional medical failure. The narrator says doctors diagnosed COPD and prescribed inhalers for life. He says the first hit helped briefly, but soon he was hitting the inhaler repeatedly and still sounding like a broken subwoofer. The VSL wants the viewer to identify with the frustration of temporary relief.

The turning point is Sam Elliott. The narrator says Sam had been through the same problem and found a doctor who discovered the real cause. This bridges celebrity testimony into medical authority. The next morning, the narrator claims he woke up and took a deep breath. Within 17 days, he says he was back in the studio for hours.

The second act uses a news-interview format. Speaker B frames the story as if it were a major broadcast segment and says a renowned lung specialist lost her medical license after discovering a breakthrough. Sam Elliott then tells his story of severe decline and recovery. His pulmonologist allegedly told him his FEV1 was at 41% and that most people at that level are on oxygen 16 hours a day.

The third act gives the mechanism. Dr. O'Neill explains the outlaw mechanism, the alleged jammed valves, and the five-ingredient formula. The VSL then adds proof elements: a claimed 2024 study, claimed patient percentages, and celebrity-style testimonials.

The final act sells. The VSL says the presentation is under attack, that a pharmaceutical company sent a cease and desist letter, that lawyers warn an injunction may arrive after midnight, and that only 847 bottles remain. Then it offers the formula for $39, adds bonuses, promises no recurring charges, and repeats the 60-day guarantee.

Ads Breakdown

The ad transcript uses even faster, sharper hooks than the main VSL. Its first line asks whether the viewer wants to hear something interesting, then claims a glass of salt water can actually reverse lung disease in just a few days. That is an extreme curiosity hook. It is simple, strange, cheap, and provocative.

The second hook is celebrity validation. The ad says the claim sounds too good to be true unless the viewer heard it from Snoop Dogg hours ago. This borrows attention from a famous person and turns the ad into a piece of alleged breaking news.

The third hook is the fridge trick angle. The ad calls it a life-changing fridge trick, which makes the solution feel ordinary and accessible. Direct-response health ads often use this structure: a serious condition, a simple household action, and a hidden explanation.

The fourth hook is the astronaut secret. The ad says the method was originally used by astronauts in space to relieve breathlessness and lung congestion. This adds novelty and authority without requiring the viewer to understand the mechanism. Space medicine sounds advanced, controlled, and elite.

The fifth hook is mass adoption. The ad first says the method helped more than 64,000 Americans get rid of the pain of COPD. Later, it says over 170,000 Americans have used it to break free from COPD. Those numbers are not reconciled in the transcript, but their function is clear: to imply that many others have already acted.

The sixth hook is anti-medical contrast. The ad says there are no inhalers, no steroids, no expensive oxygen therapy equipment. It later says no drugs, no inhalers, no gimmicks. This positions the method as cleaner, safer, and less burdensome than conventional options.

The seventh hook is censorship. The ad claims Snoop shared his story online, but Big Pharma had the video pulled down within one minute. This creates urgency and suspicion: if the viewer does not click now, the truth may vanish again.

The eighth hook is fear around existing medications. The ad claims long-term use of inhalers and COPD drugs can be as dangerous as long-term smoking and says these drugs hide symptoms rather than heal. That is a very aggressive claim in the transcript. It is used to make inaction feel risky and the alternative feel liberating.

Finally, the ad uses a direct CTA: click the link, do not wait, reclaim your lungs and your life. Its job is not to explain the formula in detail. Its job is to move people from social feed curiosity into the longer VSL, where the lung-valve story, doctor authority, testimonials, bonuses, and checkout urgency take over.

Psychological Triggers and Persuasion Tactics

The most obvious tactic in the Reinício das Válvulas Pulmonares VSL is authority bias. The script stacks several kinds of authority: celebrity, medical, media, and patient experience. Snoop Dogg supplies cultural authority. Sam Elliott supplies rugged, older-male credibility. Dr. O'Neill supplies medical authority. The NBC-style interview frame supplies media authority.

The second major tactic is unique mechanism persuasion. The VSL does not merely say the product supports breathing. It names a mechanism: the outlaw mechanism. Naming the mechanism makes the claim feel more specific and ownable. It gives the buyer a reason to believe previous approaches failed: they were aimed at airways, not valves.

The third tactic is villain creation. The villain is Big Pharma, the inhaler industry, and conventional medicine. The VSL says the inhaler industry makes $30 billion annually and that COPD patients spend an average of $4,000 per year on medications. It frames those costs as evidence that the system profits from dependency.

The fourth tactic is fear of future loss. Sam is planning his funeral. Doctors are discussing end-of-life planning. Oxygen tubes are looming. The viewer is told that every day the valves stay jammed, more permanent damage occurs. This makes delay feel dangerous.

The fifth tactic is hope through rapid timeline. The script uses timeframes like five days, seven days, 17 days, 30 days, six weeks, 60 days, and 90 days. These markers make the promised transformation feel concrete. The viewer is not being asked to imagine vague long-term wellness, but a near-term shift.

The sixth tactic is scarcity. The VSL claims only 847 bottles remain and that the next batch will not be ready for four to six months. Scarcity pushes the viewer to act before comparing alternatives or asking a doctor.

The seventh tactic is urgency by censorship. The offer may vanish after midnight because of a supposed injunction. The ad claims the video was already removed once. This creates a now-or-never environment.

The eighth tactic is price anchoring. The $39 price is compared with $300 per month inhalers, $4,000 per year medications, $200 pharmacy pricing, and $2,000 private-patient materials. Against those numbers, $39 is framed as low-risk and almost obvious.

The ninth tactic is risk reversal. The VSL offers a 60-day unconditional guarantee and says users can return empty bottles for a refund. This reduces anxiety about buying, especially when combined with the claim that no recurring charges or hidden fees are involved.

The tenth tactic is identity restoration. Buyers are not just buying capsules. They are buying the possibility of being the person they were before breathlessness: a performer, grandparent, spouse, worker, traveler, or independent adult.

Scientific and Authority Signals

The VSL uses several scientific signals, but they come from the presentation itself. The main scientific language includes alveolar capillary junctions, FEV1, thymols, glycyrrhizin, inflammatory debris, blood-lung exchange, vitamin D deficiency, and bronchial tubes.

The most important claimed evidence is the 2024 study described by Dr. O'Neill. She says she conducted a 60-day study with 1,847 COPD patients using the natural formula. The claimed results are highly specific: 94% reported easier breathing within seven days, average FEV1 improvement of 31%, 78% reduced inhaler usage by more than half by week six, and 89% could climb stairs without stopping by day 30.

Those numbers are central to the VSL's credibility. They are also presented without supporting documentation in the transcript. We do not see a study title, journal, trial design, control group, inclusion criteria, adverse-event reporting, baseline severity, statistical analysis, or independent replication. As a review grounded only in the transcript, the honest conclusion is that these are claims made in the presentation.

The VSL also uses institutional names. Dr. O'Neill is described as Harvard trained and having spent 30 years at Johns Hopkins before moving her practice to Sedona. Sam says his pulmonologist was Dr. Richards at Cedars-Sinai. Speaker B frames the segment as NBC Nightly News with Tom Yamas. These names are used to make the story feel connected to respected medical and media institutions.

The presentation also claims suppression. Dr. O'Neill allegedly lost her medical license, received a cease and desist letter from a major pharmaceutical company, and faces an injunction after midnight. These are not scientific signals in the ordinary sense, but they are authority-adjacent. They imply the discovery is powerful enough to threaten major institutions.

From an editorial standpoint, the most important issue is proportionality. The VSL's scientific language is specific, but the sales claims are sweeping. It moves from ingredient descriptions to claims about reversing COPD, reducing inhaler use, and avoiding oxygen therapy. A cautious reader should not treat those claims as proven outcomes.

What Real Buyers Say

The VSL includes several testimonial-style statements. Some are framed as recognizable voices, not ordinary verified buyers. Still, they function as social proof inside the presentation.

The Snoop-style narrator says, I can't breathe, and later says that within 17 days he was back in the studio laying down tracks for hours. He describes waking up clear, without a cough, and walking to the store without feeling like he ran a marathon.

Sam Elliott's story is the emotional anchor. He says, I was planning my funeral, not joking. He says he could not make it from his truck to the grocery store without stopping. He describes waking in bed gasping and says he had every inhaler they make. After using the method, he claims he rode his horse 12 miles without stopping once and took the deepest breath he had taken in 10 years.

The celebrity-style testimonial section adds three more voices. One says, I can work 12 hour days again, after the wheeze made long days on set difficult. Another says, I can hit those high notes again without running out of breath, after smoking and touring for more than 60 years. A third says, I can literally rock a three hour set and still have energy for after party.

The VSL also uses numerical proof. Dr. O'Neill says she helped over 1,800 patients with COPD and chronic bronchitis. The ad claims more than 64,000 Americans and later 170,000 Americans have used the method. The main VSL claims a 60-day study of 1,847 COPD patients.

As persuasive material, the testimonials are vivid. As evidence, they are limited. The transcript does not provide names of ordinary customers, before-and-after medical records, independent verification, or context about other treatments. The testimonials are best understood as part of the VSL's persuasion architecture.

The Offer / Pricing / Risk Reversal

The offer is built around a simple front-end price: $39 per bottle. The VSL says this is manufacturing cost and claims the product is only available directly from the lab. It says pharmacy distribution would require a 500% markup, pushing the price above $200 per bottle.

The price is anchored against respiratory-care expenses. The presentation claims inhalers can cost $300 per month and that a COPD patient spends an average of $4,000 per year on medications alone. The implied comparison is clear: keep paying hundreds every month for temporary relief, or pay $39 once to address the alleged root cause.

The bonuses are designed to make the order feel much bigger than a bottle. Buyers are told they receive the Complete Lung Freedom System, the Complete Lung Recovery Toolkit, the Emergency Valve Reset Protocol, the Lung Renewal Food Plan, and direct email access to the clinical team for 60 days. The VSL says 100 people will also be chosen to visit a retreat for seven days at no cost.

The guarantee is a classic direct-response risk reversal: 60 days, unconditional, empty bottles accepted, no questions asked. The transcript says buyers can try the system for two full months and receive every penny back if they do not feel they got their breath and life back.

The urgency is heavy. The VSL says a pharmaceutical company sent a cease and desist letter three weeks earlier. It claims lawyers warned that an injunction may remove every mention of the breakthrough after midnight. It also claims only 847 bottles remain and that the next batch may take four to six months, assuming the formula can still be made legally.

The checkout reassurance is also specific. The VSL says the order button will appear below the video, the transaction will be processed by a national bank, there are no hidden fees, no recurring charges, and customer service answers the phone. These details are meant to lower friction after a high-pressure pitch.

Who This Is For (and Who It Isn't)

Based on the transcript, Reinício das Válvulas Pulmonares is aimed at adults with respiratory frustration who are searching for a natural support option and feel disappointed by temporary relief from inhalers. The messaging is especially written for older viewers, former smokers, people with COPD-like symptoms, and people afraid of oxygen therapy.

It may appeal to someone who wants to understand the product's claimed formula, evaluate the VSL, and compare the stated ingredients with typical respiratory-support supplements. It may also appeal to buyers who respond to systems, protocols, food plans, and refund guarantees.

It is not for someone looking for a proven COPD cure. The VSL uses cure-like and reversal language, but this review cannot validate those claims from the transcript. COPD, chronic bronchitis, severe shortness of breath, and low FEV1 are medical issues that require qualified care.

It is also not for someone who plans to stop prescribed inhalers, oxygen therapy, or respiratory medications without medical supervision. The presentation strongly criticizes the inhaler industry, but that does not make it safe to abandon prescribed treatment.

It may not be a good fit for skeptical buyers who need published clinical trials, dosage transparency, third-party testing, and clear safety disclosures before purchasing. The transcript provides persuasive claims, but not the level of documentation a research-driven buyer would normally want.

Frequently Asked Questions

What is Reinício das Válvulas Pulmonares?

Reinício das Válvulas Pulmonares is presented as a respiratory support formula and system. According to the VSL, it is designed to target jammed lung-blood valves and help people breathe more easily. That is the manufacturer's claim, not a verified medical conclusion.

What ingredients are mentioned?

The named ingredients are mullein leaf extract, organic thyme extract, ginger root complex, licorice root, and vitamin D3. The transcript does not disclose exact dosages or a full Supplement Facts panel.

Does it cure COPD?

No supplement should be treated as a COPD cure. The VSL uses aggressive claims about reversing COPD and reducing inhaler use, but those claims come from the sales presentation. People with COPD should consult qualified medical professionals.

What is the outlaw mechanism?

The outlaw mechanism is the VSL's name for its claimed root cause: jammed alveolar capillary junctions that supposedly trap toxins and create a loop between the bloodstream and lungs. It is the offer's unique mechanism claim.

How much does it cost?

The presentation says the product costs $39 per bottle. It compares that price with $300 monthly inhalers, $4,000 yearly medication costs, and a potential pharmacy price above $200.

What bonuses are included?

The VSL mentions a Complete Lung Freedom System, Lung Recovery Toolkit, Emergency Valve Reset Protocol, Lung Renewal Food Plan, email access to a clinical team, and a possible retreat opportunity for selected buyers.

What guarantee is offered?

The transcript says there is a 60-day unconditional guarantee. Buyers are told they can send back empty bottles and receive a full refund if they are not satisfied.

What are the biggest red flags?

The biggest red flags are the intense urgency, censorship claims, celebrity framing, legal takedown story, lack of dosage transparency in the transcript, and claims that a supplement could reverse COPD or make inhalers unnecessary.

Final Take

Reinício das Válvulas Pulmonares is a high-intensity respiratory supplement offer built around one memorable claim: breathing problems are caused by jammed lung valves, not simply damaged lungs. The presentation says its formula uses mullein, thyme, ginger, licorice, and vitamin D3 to address this alleged root cause.

As a direct-response VSL, it is sophisticated. It uses celebrity voices, medical authority, a named mechanism, emotional decline-and-recovery stories, study-like statistics, a low entry price, bonuses, scarcity, censorship, and a refund guarantee. The ad funnel adds even more curiosity with a salt water fridge trick, astronaut method, and Big Pharma takedown claim.

As a health claim, it demands caution. The transcript makes strong statements about COPD, inhaler dependence, FEV1 improvement, and restored lung function, but it does not provide the kind of independent clinical evidence, dosage transparency, or safety context needed to treat those claims as proven. The most responsible reading is this: the manufacturer claims the formula supports breathing by targeting the outlaw mechanism, but people with serious respiratory symptoms should not use the VSL as a substitute for medical care.

For researchers, affiliates, and buyers analyzing the offer, the takeaway is clear. The product's marketing strength is its unique mechanism and emotional storytelling. Its main weakness is the gap between the certainty of the claims and the evidence actually visible in the transcript.

Disclaimer: This article is for research and educational purposes only. It is not medical, legal, or financial advice, and it is not affiliated with the product or its makers. Always consult a qualified professional before making health or financial decisions.